Use of stentless xenografts in the aortic position: Determinants of early and late outcome

Annals of Thoracic Surgery

Volumn 74, Issue 5, 2002, Pages 1450-1457

  Akar, A Ruchan ^a   Szafranek, Adam ^a   Alexiou, Christos ^a   Janas, Robert ^a   Jasinski, Marek J ^a   Swanevelder, Justiaan ^a   Sosnowski, Andrzej W ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; ENDOCARDITIS; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; REOPERATION; STENT; THROMBOEMBOLISM; TREATMENT OUTCOME; XENOGRAFT;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; REOPERATION; RETROSPECTIVE STUDIES; STENTS; SURVIVAL RATE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036839845     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)03845-6     Document Type: Article

References (29)

1. Bonow RO, Carabello B, de Leon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998;98:1949-84.
2. Levy D. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990;322:1561-6.
3. McGiffin D, O'Brien M, Galbraith A, et al. An analysis of risk factors for death and mode-specific death after aortic valve replacement with allograft, xenograft, and mechanical valves. J Thorac Cardiovasc Surg 1993;106:895-911.
4. Del Rizzo DF, Goldman BS, Christakis GT, David TE. Hemodynamic benefits of the Toronto Stentless Valve. J Thorac Cardiovasc Surg 1996;112:1431-45.
5. Ross DN. Homograft replacement of the aortic valve. Lancet 1962;2:487-8.
6. David TE, Ropchan GC, Butany JW. Aortic valve replacement with stentless porcine bioprostheses. J Card Surg 1988; 3:501-5.
7. Goldman BS, David TE, Wood JR, et al. Clinical outcomes after aortic valve replacement with the Toronto stentless porcine valve. Ann Thorac Surg 2001;71(Suppl):S302-5.
8. Luciani GB, Bertolini P, Vecchi B, Barozzi L, Casali G, Mazzucco A. Stentless aortic xenograft valve replacement: Lessons learned after 300 implants. Semin Thorac Cardiovasc Surg 1999;11:139-44.
9. Bach DS, David T, Yacoub M, et al. Hemodynamics and left ventricular mass regression following implantation of the Toronto SPV stentless porcine valve. Am J Cardiol 1998;82:1214-9.
10. Dumesnil JG, Leblanc MH, Cartier PC, et al. Hemodynamic features of the freestyle aortic bioprosthesis compared with stented bioprosthesis. Ann Thorac Surg 1998;66(Suppl):S130-3.
11. Eriksson MJ, Rosfors S, Radegran K, Brodin LA. Effects of exercise on Doppler-derived pressure difference, valve resistance, and effective orifice area in different aortic valve prostheses of similar size [see comments]. Am J Cardiol 1999;83:619-22, A10.
12. Sintek CF, Pfeffer TA, Kochamba GS, Yun KL, Fletcher AD, Khonsari S. Freestyle valve experience: Technical considerations and mid-term results. J Card Surg 1998;13:360-8.
13. Abolhoda A, Yu S, Oyarzun R, McCormick JR, Bogden JD, Gabbay S. Calcification of bovine pericardium: Glutaraldehyde versus No-React biomodification. Ann Thorac Surg 1996;62:169-74.
14. Rubay JE, El Khoury G, Buche M. Aortic valve replacement with the stentless bovine pericardial valve: Early experience with the Sorin valve. In: Huysmans HA, David TE, Westaby S, eds. Stentless Bioprostheses, 2nd Ed. Oxford: Isis Medical Media, Herndon, VA, 1999:47-51.
15. O'Brien MF. The Cryolife-O'Brien composite aortic stentless xenograft: Surgical technique of implantation. Ann Thorac Surg 1995;60(Suppl):S410-3.
16. Konertz W, Weyand M, Sidiropoulos A, Schwammenthal E, Breithardt G, Scheld HH. Technique of aortic valve replacement with the Edwards stentless aortic bioprosthesis 2500. Eur J Cardiothorac Surg 1992;6:274-7.
17. David TE, Bos J, Rakowski H. Aortic valve replacement with the Toronto SPV bioprosthesis. J Heart Valve Dis 1992;1:244-8.
18. Edmunds LHJ, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-5.
19. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis: Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med 1993;328:1289-96.
20. Lindblom D, Lindblom U, Qvist J, Lundstrom H. Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol 1990;15:566-73.
21. Fries R, Wendler O, Schieffer H, Schafers HJ. Comparative rest and exercise hemodynamics of 23-mm stentless versus 23-mm stented aortic bioprostheses. Ann Thorac Surg 2000; 69:817-22.
22. Westaby S, Horton M, Jin XY, et al. Survival advantage of stentless aortic bioprostheses. Ann Thorac Surg 2000;70:785-90.
23. Berg GA, McLaughlin KE, Akar R, Pathi V, MacArthur KJ. A three year experience with the Toronto stentless porcine valve. Ann Thorac Cardiovasc Surg 1998;4:138-45.
24. Jamieson WR, Edwards FH, Schwartz M, Bero JW, Clark RE, Grover FL. Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Ann Thorac Surg 1999; 67:943-51.
25. Doty DB, Cafferty A, Cartier P, et al. Aortic valve replacement with Medtronic Freestyle bioprosthesis: 5-Year results. Semin Thorac Cardiovasc Surg 1999;11:35-41.
26. Hvass U, O'Brien MF. The stentless Cryolife-O'Brien aortic porcine xenograft: A five-year follow-up. Ann Thorac Surg 1998;66(Suppl):S134-8.
27. Gelsomino S, Frassani R, Morocutti G, et al. Left ventricular mass regression after aortic valve replacement with CryoLife-O'Brien stentless aortic bioprosthesis. J Heart Valve Dis 2001;10:603-10.
28. Gelsomino S, Frassani R, Morocutti G, et al. Time course of left ventricular remodeling after stentless aortic valve replacement. Am Heart J 2001;142:556-62.
29. Bach DS. Echocardiographic assessment of stentless aortic bioprosthetic valves. J Am Soc Echocardiogr 2000;13:941-8.